A biological agent for reducing oxidative damage of bovine oocytes

By using KR-12amide antibacterial peptide to reduce the oxidative damage of bovine oocytes, improve its maturity rate and blastocyst development rate, the problem of oxidative damage of bovine oocytes during in vitro maturation is solved, and higher maturity quality and Security.

CN116218767BActive Publication Date: 2024-12-06QINGDAO PUXING BIO TECH CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202310109147.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-02-10
Publication Date
2024-12-06
Estimated Expiration
2043-02-10

AI Technical Summary

Technical Problem

During the maturation process in vitro, bovine oocytes are susceptible to factors such as metabolites, temperature, CO2 concentration and oxygen concentration, resulting in oxidative damage, which in turn reduces maturation rate and development potential.

Method used

Using KR-12amide antimicrobial peptide as a core component to reduce the oxidative damage of bovine oocytes by reducing reactive oxygen species (ROS) and increasing the glutathione (GSH) content.

Benefits of technology

It significantly improves the maturity, maturation ability and blastocyst development rate of bovine oocytes, broadens the application range of KR-12amide antimicrobial peptides, and is safer and more effective due to the stability and fewer side effects of polypeptide drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116218767B_ABST
    Figure CN116218767B_ABST
Patent Text Reader

Abstract

The present invention provides a biological preparation for reducing oxidative damage to bovine oocytes, and belongs to the field of animal breeding technology. Specifically, the present invention applies the antimicrobial peptide KR-12amide to the technical field of bovine oocyte maturation and oxidative damage. The present invention finds that the antimicrobial peptide KR-12amide can effectively reduce the oxidative damage of bovine oocytes and improve the maturation ability and maturation quality of bovine oocytes, which expands the application scope of the antimicrobial peptide KR-12amide, and the polypeptide drug has the advantages of strong stability and few side effects, and is safer and more effective in the application of bovine oocyte breeding.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of animal reproduction, and in particular relates to a biological preparation for alleviating oxidative damage of bovine oocytes. Background Art

[0002] With the increasing demand for high-quality beef, the traditional breeding model can no longer meet the current market needs. Therefore, embryo engineering technology has become increasingly important. Embryo engineering technology can give full play to the reproductive capacity of cows, accelerate the selection of excellent quality, and improve the shortcomings of traditional cattle breeding. However, the in vitro quality and developmental potential of bovine oocytes are significantly lower than those of oocytes in vivo. The reason is that the maturation process of oocytes in vitro will be affected by metabolites, temperature, CO2 concentration, humidity, oxygen concentration and other factors. Among these factors, metabolism, high oxygen concentration, etc. will lead to the production of reactive oxygen species. Excessive accumulation of reactive oxygen species will cause damage to oocytes, resulting in poor cell maturation quality. Therefore, effectively reducing oxidative damage to bovine oocytes is the key to improving the maturation rate and development rate of oocytes.

[0003] KR-12amide is a derivative peptide of the antimicrobial peptide LL-37. During the sequence modification, an amide bond was added to the C-terminus, and the physiological activity of the peptide was changed by blocking the C-terminus. The amino acid sequence of KR-12amide is H2N-KRIVQRIKDFLR-NH2, and the average molecular weight is 1569.99. Some studies have shown that KR-12amide has excellent antibacterial effects and specificity, but there is no literature report on whether the antimicrobial peptide KR-12amide can play a role in reducing oxidative damage in bovine oocytes. Summary of the invention

[0004] The purpose of the present invention is to explore the new application of antimicrobial peptide KR-12amide in reducing oxidative damage of bovine oocytes.

[0005] In order to achieve the above object, the present invention provides the following technical solutions:

[0006] Firstly, the present invention provides a biological preparation for reducing oxidative damage of bovine oocytes, wherein the core active ingredient of the biological preparation is KR-12amide antimicrobial peptide.

[0007] Preferably, the biological preparation also includes IVM maturation fluid.

[0008] Preferably, the biological agent reduces the ROS content and increases the GSH content in bovine oocytes.

[0009] Secondly, the present invention provides a culture medium for reducing oxidative damage to bovine oocytes, wherein the culture medium is IVM maturation fluid, and the culture medium contains 5 μg / ml KR-12amide antimicrobial peptide.

[0010] Thirdly, the present invention provides the use of KR-12amide antimicrobial peptide in preparing a culture medium for improving the maturation ability of bovine oocytes.

[0011] Preferably, the culture medium is IVM maturation fluid.

[0012] Preferably, the content of KR-12amide antimicrobial peptide in the culture medium is 5 μg / ml.

[0013] Fourthly, the present invention provides a culture medium for improving the maturation ability of bovine oocytes, wherein the culture medium is IVM maturation solution, and the culture medium contains 5 μg / ml KR-12amide antimicrobial peptide.

[0014] Fifthly, the present invention provides the use of KR-12amide antimicrobial peptide in preparing a culture medium for improving the maturation quality of bovine oocytes.

[0015] Preferably, the culture medium is IVM maturation fluid.

[0016] Preferably, the content of KR-12amide antimicrobial peptide in the culture medium is 5 μg / ml.

[0017] Sixth, the present invention provides a culture medium for improving the maturation quality of bovine oocytes, wherein the culture medium is IVM maturation fluid, and the culture medium contains 5 μg / ml KR-12amide antimicrobial peptide.

[0018] The beneficial effects of the present invention are:

[0019] The present invention explores the new application of KR-12amide antimicrobial peptide in reducing oxidative damage of bovine oocytes and improving the maturation ability and quality of bovine soft membrane cells, and expands the application scope of KR-12amide antimicrobial peptide.

[0020] Secondly, peptide drugs have the advantages of strong stability and few side effects, and are safer and more effective in bovine oocyte breeding applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 The difference in maturation rate of bovine oocytes treated with and without antimicrobial peptide KR-12amide treatment;

[0022] Figure 2The difference of ROS content in bovine oocytes treated with antimicrobial peptide KR-12amide and not treated with antimicrobial peptide KR-12amide, A is the result of fluorescence microscopy, B is the statistical result;

[0023] Figure 3 The difference of GSH content in bovine oocytes treated with antimicrobial peptide KR-12amide and not treated with antimicrobial peptide KR-12amide, A is the result of fluorescence microscopy, B is the statistical result;

[0024] Figure 4 The difference between bovine oocyte parthenogenesis after treatment with antimicrobial peptide KR-12amide and without treatment with antimicrobial peptide KR-12amide. A is the cleavage rate result, and B is the blastocyst development rate result. DETAILED DESCRIPTION

[0025] Example 1

[0026] 1) Obtain the bovine ovaries (Chinese yellow cattle) required for the experiment from the slaughterhouse, and preheat the physiological saline in an incubator at about 38.5°C before the experiment;

[0027] 2) After using scissors to remove excess tissue around the bovine ovary, use sterile saline to clean the impurities and blood on the surface of the bovine ovary;

[0028] 3) Use a 10ml syringe and a No. 12 pillow to puncture and aspirate the oocytes in the 2-8mm diameter follicles on the ovary;

[0029] 4) Transfer the follicular fluid to a 60 mm culture dish and identify the cumulus-oocyte complex containing more than three layers of granulosa cells and uniform cytoplasm under a stereoscope;

[0030] 5) After washing the collected cumulus-oocyte complexes three times in egg washing solution, they were placed in cell culture plates containing IVM maturation solution with different concentrations (0, 15 μg / ml) of KR-12amide, and the cell culture plates were placed in an incubator at 38.5°C and 5CO2 for 42 hours;

[0031] 6) The cultured cumulus-oocyte complex was digested with 0.1% hyaluronidase to remove the cumulus cells. After terminating the digestion with a stop solution, mature oocytes with the first polar body (considered mature) were selected under a stereoscope and the maturation rate was calculated.

[0032] The results of Example 1 of the present invention are shown in Figure 1 In, from Figure 1We can see that the maturation rate of oocytes not treated with KR-12amide is 66.76%, while the maturation rate of oocytes treated with KR-12amide is 76.36%, which is significantly higher than that of untreated cells, indicating that KR-12amide has the ability to promote the maturation of bovine oocytes.

[0033] Example 2

[0034] 1) First, the reactive oxygen species (ROS) fluorescent probe (DCFH-DA) was diluted into 10 μmol / L TCM-199 working solution and made into microdroplets, covered with mineral oil, and equilibrated in a sterile incubator at 38.5°C and 5% CO2 for 30 minutes;

[0035] 2) Select mature oocytes (divided into con group (mature cells treated with IVM maturation solution containing 0 μg / ml KR-12amide) and KR-12amide treatment group (mature cells treated with IVM maturation solution containing 15 μg / ml KR-12amide)), wash them three times with PBS, put them into the prepared DCFH-DA dilution solution, and incubate them in an incubator at 38.5°C and 5% CO2 for 30 min in the dark;

[0036] 3) After washing three times with PBS containing 0.1% BSA, the cells were photographed under a fluorescence microscope and the optical density was calculated.

[0037] The results of Example 2 of the present invention are shown in Figure 2 In, from Figure 2 We can see that compared with the con group, the fluorescence density of ROS in oocytes treated with KR-12amide was significantly reduced (reduced by 42%), indicating that KR-12amide treatment can effectively reduce the ROS content in oocytes.

[0038] Example 3

[0039] 1) First, set ThiolTracker TM Violet was diluted to 10 μmol / L in TCM-199 working solution and made into microdroplets, covered with mineral oil, and equilibrated in a sterile incubator at 38.5°C and 5% CO2 for 30 min;

[0040] 2) Select mature oocytes (divided into con group (mature cells treated with IVM maturation solution containing 0 μg / ml KR-12amide) and KR-12amide treatment group (mature cells treated with IVM maturation solution containing 15 μg / ml KR-12amide)), wash them with PBS three times, and place the cells in the prepared ThiolTrackerTM Violet dilution solution, and incubate the cells in a 38.5°C, 5% CO2 incubator in the dark for 30 min;

[0041] 3) After washing three times with PBS containing 0.1% BSA, the cells were photographed under a fluorescence microscope and the optical density was calculated.

[0042] The results of the present invention are shown in Figure 3 In, from Figure 3 We can see that compared with the con group, the optical density of GSH in oocytes treated with KR-12amide was significantly increased (increased by 59.3%), indicating that KR-12amide treatment can effectively increase the GSH content in oocytes.

[0043] Example 4

[0044] 1) Mature oocytes (divided into con group (mature cells treated with IVM maturation solution containing 0 μg / ml KR-12amide) and KR-12amide treatment group (mature cells treated with IVM maturation solution containing 15 μg / ml KR-12amide)) were added to 5 μmol / L ionase-containing oocyte washing solution for activation for 5 min;

[0045] 2) Transfer to 2mmol / L 6-DMAP culture medium and culture for 6h, wash 2-3 times with culture medium, place in IVC culture medium, and culture in an incubator;

[0046] 3) After 48 hours, the cleavage rate of cells was counted, and after 7 days, the blastocyst rate was counted.

[0047] The results of the present invention are shown in Figure 4 In, from Figure 4 We can see that compared with the con group (cleavage rate 63.87±3.06, blastocyst development rate 22.67±1.95), the cleavage rate (71.94±3.32) and blastocyst development rate (29.80±1.74) of oocytes treated with KR-12amide were significantly increased.

[0048] Based on Examples 1-4, it can be seen that KR-12amide has the ability to promote bovine oocyte maturation, remove active oxygen in bovine oocytes, increase antioxidant enzyme activity (inhibit oxidative damage), and improve the quality of bovine oocyte maturation, and the ability to inhibit oxidative damage is superior to the ability to promote bovine oocyte maturation and improve the quality of oocyte maturation.

Claims

1. A culture medium for reducing oxidative damage to bovine oocytes, characterized in that: The culture medium is an IVM maturation solution containing 15 μg / ml KR-12 amide antimicrobial peptide.

2. The use of KR-12 amide antimicrobial peptide in the preparation of a culture medium for improving the maturation ability of bovine oocytes, characterized in that: The culture medium is an IVM maturation solution containing 15 μg / ml KR-12 amide antimicrobial peptide.

Citation Information

Patent Citations

  • Antibacterial peptide-loaded multifunctional gel as well as preparation method and application thereof

    CN117257721A